Efficacy of abemaciclib versus tucidinostat after progression on palbociclib in patients with HR+/HER22 MBC: A multicenter retrospective cohort study
JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)